President and Chief Executive Officer
Exelixis Pharmaceuticals

George A. Scangos, Ph.D., President and Chief Executive Officer, joined Exelixis in October 1996 from Bayer Biotechnology. At Bayer he held positions of increasing responsibility, from Senior Staff Scientist to Senior Vice President of Research and Development for North America and ultimately as President of Bayer Biotechnology. As President of Bayer Biotechnology, Dr. Scangos was responsible for 1,100 employees in research & development, business development, process development, manufacturing, engineering, and quality assurance. Prior to Bayer, Dr. Scangos was on the faculty of The Johns Hopkins University where he now holds an appointment as Adjunct Professor of Biology. He serves on the Board of Visitors, at the University of California, San Francisco School of Pharmacy, the Board of Overseers at the University of California, Davis Medical School Board and the Board of Directors at Entelos, Inc. Dr. Scangos holds a Ph.D. in Microbiology from the University of Massachusetts, and was a Jane Coffin Childs Postdoctoral Fellow.